Literature DB >> 33359885

Common and Rare Variant Prediction and Penetrance of IBD in a Large, Multi-ethnic, Health System-based Biobank Cohort.

Kyle Gettler1, Rachel Levantovsky1, Arden Moscati2, Mamta Giri1, Yiming Wu2, Nai-Yun Hsu1, Ling-Shiang Chuang1, Aleksejs Sazonovs3, Suresh Venkateswaran4, Ujunwa Korie2, Colleen Chasteau2, Richard H Duerr5, Mark S Silverberg6, Scott B Snapper7, Mark J Daly8, Dermot P McGovern9, Steven R Brant10, John D Rioux11, Subra Kugathasan12, Carl A Anderson3, Yuval Itan2, Judy H Cho13.   

Abstract

BACKGROUND AND AIMS: Polygenic risk scores (PRS) may soon be used to predict inflammatory bowel disease (IBD) risk in prevention efforts. We leveraged exome-sequence and single nucleotide polymorphism (SNP) array data from 29,358 individuals in the multiethnic, randomly ascertained health system-based BioMe biobank to define effects of common and rare IBD variants on disease prediction and pathophysiology.
METHODS: PRS were calculated from European, African American, and Ashkenazi Jewish (AJ) reference case-control studies, and a meta-GWAS run using all three association datasets. PRS were then combined using regression to assess which combination of scores best predicted IBD status in European, AJ, Hispanic, and African American cohorts in BioMe. Additionally, rare variants were assessed in genes associated with very early-onset IBD (VEO-IBD), by estimating genetic penetrance in each BioMe population.
RESULTS: Combining risk scores based on association data from distinct ancestral populations improved IBD prediction for every population in BioMe and significantly improved prediction among European ancestry UK Biobank individuals. Lower predictive power for non-Europeans was observed, reflecting in part substantially lower African IBD case-control reference sizes. We replicated associations for two VEO-IBD genes, ADAM17 and LRBA, with high dominant model penetrance in BioMe. Autosomal recessive LRBA risk alleles are associated with severe, early-onset autoimmunity; we show that heterozygous carriage of an African-predominant LRBA protein-altering allele is associated with significantly decreased LRBA and CTLA-4 expression with T-cell activation.
CONCLUSIONS: Greater genetic diversity in African populations improves prediction across populations, and generalizes some VEO-IBD genes. Increasing African American IBD case-collections should be prioritized to reduce health disparities and enhance pathophysiological insight.
Copyright © 2021 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  IBD; PRS; VEO-IBD

Mesh:

Year:  2020        PMID: 33359885      PMCID: PMC8237248          DOI: 10.1053/j.gastro.2020.12.034

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   33.883


  44 in total

Review 1.  Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology.

Authors:  Eva Schrezenmeier; Thomas Dörner
Journal:  Nat Rev Rheumatol       Date:  2020-02-07       Impact factor: 20.543

2.  Genome-Wide Association Study Identifies African-Specific Susceptibility Loci in African Americans With Inflammatory Bowel Disease.

Authors:  Steven R Brant; David T Okou; Claire L Simpson; David J Cutler; Talin Haritunians; Jonathan P Bradfield; Pankaj Chopra; Jarod Prince; Ferdouse Begum; Archana Kumar; Chengrui Huang; Suresh Venkateswaran; Lisa W Datta; Zhi Wei; Kelly Thomas; Lisa J Herrinton; Jan-Micheal A Klapproth; Antonio J Quiros; Jenifer Seminerio; Zhenqiu Liu; Jonathan S Alexander; Robert N Baldassano; Sharon Dudley-Brown; Raymond K Cross; Themistocles Dassopoulos; Lee A Denson; Tanvi A Dhere; Gerald W Dryden; John S Hanson; Jason K Hou; Sunny Z Hussain; Jeffrey S Hyams; Kim L Isaacs; Howard Kader; Michael D Kappelman; Jeffry Katz; Richard Kellermayer; Barbara S Kirschner; John F Kuemmerle; John H Kwon; Mark Lazarev; Ellen Li; David Mack; Peter Mannon; Dedrick E Moulton; Rodney D Newberry; Bankole O Osuntokun; Ashish S Patel; Shehzad A Saeed; Stephan R Targan; John F Valentine; Ming-Hsi Wang; Martin Zonca; John D Rioux; Richard H Duerr; Mark S Silverberg; Judy H Cho; Hakon Hakonarson; Michael E Zwick; Dermot P B McGovern; Subra Kugathasan
Journal:  Gastroenterology       Date:  2016-09-28       Impact factor: 22.682

3.  Primary immunodeficiency diseases: Genomic approaches delineate heterogeneous Mendelian disorders.

Authors:  Asbjørg Stray-Pedersen; Hanne Sørmo Sorte; Pubudu Samarakoon; Tomasz Gambin; Ivan K Chinn; Zeynep H Coban Akdemir; Hans Christian Erichsen; Lisa R Forbes; Shen Gu; Bo Yuan; Shalini N Jhangiani; Donna M Muzny; Olaug Kristin Rødningen; Ying Sheng; Sarah K Nicholas; Lenora M Noroski; Filiz O Seeborg; Carla M Davis; Debra L Canter; Emily M Mace; Timothy J Vece; Carl E Allen; Harshal A Abhyankar; Philip M Boone; Christine R Beck; Wojciech Wiszniewski; Børre Fevang; Pål Aukrust; Geir E Tjønnfjord; Tobias Gedde-Dahl; Henrik Hjorth-Hansen; Ingunn Dybedal; Ingvild Nordøy; Silje F Jørgensen; Tore G Abrahamsen; Torstein Øverland; Anne Grete Bechensteen; Vegard Skogen; Liv T N Osnes; Mari Ann Kulseth; Trine E Prescott; Cecilie F Rustad; Ketil R Heimdal; John W Belmont; Nicholas L Rider; Javier Chinen; Tram N Cao; Eric A Smith; Maria Soledad Caldirola; Liliana Bezrodnik; Saul Oswaldo Lugo Reyes; Francisco J Espinosa Rosales; Nina Denisse Guerrero-Cursaru; Luis Alberto Pedroza; Cecilia M Poli; Jose L Franco; Claudia M Trujillo Vargas; Juan Carlos Aldave Becerra; Nicola Wright; Thomas B Issekutz; Andrew C Issekutz; Jordan Abbott; Jason W Caldwell; Diana K Bayer; Alice Y Chan; Alessandro Aiuti; Caterina Cancrini; Eva Holmberg; Christina West; Magnus Burstedt; Ender Karaca; Gözde Yesil; Hasibe Artac; Yavuz Bayram; Mehmed Musa Atik; Mohammad K Eldomery; Mohammad S Ehlayel; Stephen Jolles; Berit Flatø; Alison A Bertuch; I Celine Hanson; Victor W Zhang; Lee-Jun Wong; Jianhong Hu; Magdalena Walkiewicz; Yaping Yang; Christine M Eng; Eric Boerwinkle; Richard A Gibbs; William T Shearer; Robert Lyle; Jordan S Orange; James R Lupski
Journal:  J Allergy Clin Immunol       Date:  2016-07-16       Impact factor: 10.793

4.  Next-generation genotype imputation service and methods.

Authors:  Sayantan Das; Lukas Forer; Sebastian Schönherr; Carlo Sidore; Adam E Locke; Alan Kwong; Scott I Vrieze; Emily Y Chew; Shawn Levy; Matt McGue; David Schlessinger; Dwight Stambolian; Po-Ru Loh; William G Iacono; Anand Swaroop; Laura J Scott; Francesco Cucca; Florian Kronenberg; Michael Boehnke; Gonçalo R Abecasis; Christian Fuchsberger
Journal:  Nat Genet       Date:  2016-08-29       Impact factor: 38.330

5.  Chloroquine for mild to moderately active ulcerative colitis: comparison with sulfasalazine.

Authors:  M K Goenka; R Kochhar; B Tandia; S K Mehta
Journal:  Am J Gastroenterol       Date:  1996-05       Impact factor: 10.864

6.  Genetic and epigenetic fine mapping of causal autoimmune disease variants.

Authors:  Kyle Kai-How Farh; Alexander Marson; Jiang Zhu; Markus Kleinewietfeld; William J Housley; Samantha Beik; Noam Shoresh; Holly Whitton; Russell J H Ryan; Alexander A Shishkin; Meital Hatan; Marlene J Carrasco-Alfonso; Dita Mayer; C John Luckey; Nikolaos A Patsopoulos; Philip L De Jager; Vijay K Kuchroo; Charles B Epstein; Mark J Daly; David A Hafler; Bradley E Bernstein
Journal:  Nature       Date:  2014-10-29       Impact factor: 49.962

7.  Fine-mapping inflammatory bowel disease loci to single-variant resolution.

Authors:  Hailiang Huang; Ming Fang; Luke Jostins; Maša Umićević Mirkov; Gabrielle Boucher; Carl A Anderson; Vibeke Andersen; Isabelle Cleynen; Adrian Cortes; François Crins; Mauro D'Amato; Valérie Deffontaine; Julia Dmitrieva; Elisa Docampo; Mahmoud Elansary; Kyle Kai-How Farh; Andre Franke; Ann-Stephan Gori; Philippe Goyette; Jonas Halfvarson; Talin Haritunians; Jo Knight; Ian C Lawrance; Charlie W Lees; Edouard Louis; Rob Mariman; Theo Meuwissen; Myriam Mni; Yukihide Momozawa; Miles Parkes; Sarah L Spain; Emilie Théâtre; Gosia Trynka; Jack Satsangi; Suzanne van Sommeren; Severine Vermeire; Ramnik J Xavier; Rinse K Weersma; Richard H Duerr; Christopher G Mathew; John D Rioux; Dermot P B McGovern; Judy H Cho; Michel Georges; Mark J Daly; Jeffrey C Barrett
Journal:  Nature       Date:  2017-06-28       Impact factor: 49.962

8.  Targeted capture and massively parallel sequencing of 12 human exomes.

Authors:  Sarah B Ng; Emily H Turner; Peggy D Robertson; Steven D Flygare; Abigail W Bigham; Choli Lee; Tristan Shaffer; Michelle Wong; Arindam Bhattacharjee; Evan E Eichler; Michael Bamshad; Deborah A Nickerson; Jay Shendure
Journal:  Nature       Date:  2009-08-16       Impact factor: 49.962

9.  Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease.

Authors:  Luke Jostins; Stephan Ripke; Rinse K Weersma; Richard H Duerr; Dermot P McGovern; Ken Y Hui; James C Lee; L Philip Schumm; Yashoda Sharma; Carl A Anderson; Jonah Essers; Mitja Mitrovic; Kaida Ning; Isabelle Cleynen; Emilie Theatre; Sarah L Spain; Soumya Raychaudhuri; Philippe Goyette; Zhi Wei; Clara Abraham; Jean-Paul Achkar; Tariq Ahmad; Leila Amininejad; Ashwin N Ananthakrishnan; Vibeke Andersen; Jane M Andrews; Leonard Baidoo; Tobias Balschun; Peter A Bampton; Alain Bitton; Gabrielle Boucher; Stephan Brand; Carsten Büning; Ariella Cohain; Sven Cichon; Mauro D'Amato; Dirk De Jong; Kathy L Devaney; Marla Dubinsky; Cathryn Edwards; David Ellinghaus; Lynnette R Ferguson; Denis Franchimont; Karin Fransen; Richard Gearry; Michel Georges; Christian Gieger; Jürgen Glas; Talin Haritunians; Ailsa Hart; Chris Hawkey; Matija Hedl; Xinli Hu; Tom H Karlsen; Limas Kupcinskas; Subra Kugathasan; Anna Latiano; Debby Laukens; Ian C Lawrance; Charlie W Lees; Edouard Louis; Gillian Mahy; John Mansfield; Angharad R Morgan; Craig Mowat; William Newman; Orazio Palmieri; Cyriel Y Ponsioen; Uros Potocnik; Natalie J Prescott; Miguel Regueiro; Jerome I Rotter; Richard K Russell; Jeremy D Sanderson; Miquel Sans; Jack Satsangi; Stefan Schreiber; Lisa A Simms; Jurgita Sventoraityte; Stephan R Targan; Kent D Taylor; Mark Tremelling; Hein W Verspaget; Martine De Vos; Cisca Wijmenga; David C Wilson; Juliane Winkelmann; Ramnik J Xavier; Sebastian Zeissig; Bin Zhang; Clarence K Zhang; Hongyu Zhao; Mark S Silverberg; Vito Annese; Hakon Hakonarson; Steven R Brant; Graham Radford-Smith; Christopher G Mathew; John D Rioux; Eric E Schadt; Mark J Daly; Andre Franke; Miles Parkes; Severine Vermeire; Jeffrey C Barrett; Judy H Cho
Journal:  Nature       Date:  2012-11-01       Impact factor: 49.962

10.  Exploring the genetic architecture of inflammatory bowel disease by whole-genome sequencing identifies association at ADCY7.

Authors:  Yang Luo; Katrina M de Lange; Luke Jostins; Loukas Moutsianas; Joshua Randall; Nicholas A Kennedy; Christopher A Lamb; Shane McCarthy; Tariq Ahmad; Cathryn Edwards; Eva Goncalves Serra; Ailsa Hart; Chris Hawkey; John C Mansfield; Craig Mowat; William G Newman; Sam Nichols; Martin Pollard; Jack Satsangi; Alison Simmons; Mark Tremelling; Holm Uhlig; David C Wilson; James C Lee; Natalie J Prescott; Charlie W Lees; Christopher G Mathew; Miles Parkes; Jeffrey C Barrett; Carl A Anderson
Journal:  Nat Genet       Date:  2017-01-09       Impact factor: 41.307

View more
  9 in total

1.  IBD risk prediction using multi-ethnic polygenic risk scores.

Authors:  Ashwin N Ananthakrishnan
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-02-05       Impact factor: 46.802

2.  De novo germline mutation in the dual specificity phosphatase 10 gene accelerates autoimmune diabetes.

Authors:  Anne-Perrine Foray; Sophie Candon; Sara Hildebrand; Cindy Marquet; Fabrice Valette; Coralie Pecquet; Sebastien Lemoine; Francina Langa-Vives; Michael Dumas; Peipei Hu; Pere Santamaria; Sylvaine You; Stephen Lyon; Lindsay Scott; Chun Hui Bu; Tao Wang; Darui Xu; Eva Marie Y Moresco; Claudio Scazzocchio; Jean-François Bach; Bruce Beutler; Lucienne Chatenoud
Journal:  Proc Natl Acad Sci U S A       Date:  2021-11-23       Impact factor: 11.205

3.  Stratification of risk of progression to colectomy in ulcerative colitis via measured and predicted gene expression.

Authors:  Angela Mo; Sini Nagpal; Kyle Gettler; Talin Haritunians; Mamta Giri; Yael Haberman; Rebekah Karns; Jarod Prince; Dalia Arafat; Nai-Yun Hsu; Ling-Shiang Chuang; Carmen Argmann; Andrew Kasarskis; Mayte Suarez-Farinas; Nathan Gotman; Emebet Mengesha; Suresh Venkateswaran; Paul A Rufo; Susan S Baker; Cary G Sauer; James Markowitz; Marian D Pfefferkorn; Joel R Rosh; Brendan M Boyle; David R Mack; Robert N Baldassano; Sapana Shah; Neal S LeLeiko; Melvin B Heyman; Anne M Griffiths; Ashish S Patel; Joshua D Noe; Sonia Davis Thomas; Bruce J Aronow; Thomas D Walters; Dermot P B McGovern; Jeffrey S Hyams; Subra Kugathasan; Judy H Cho; Lee A Denson; Greg Gibson
Journal:  Am J Hum Genet       Date:  2021-08-26       Impact factor: 11.025

Review 4.  Genetics of irritable bowel syndrome: shifting gear via biobank-scale studies.

Authors:  Michael Camilleri; Alexandra Zhernakova; Isotta Bozzarelli; Mauro D'Amato
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2022-08-10       Impact factor: 73.082

Review 5.  Are polygenic risk scores ready for the cancer clinic?-a perspective.

Authors:  Robert J Klein; Zeynep H Gümüş
Journal:  Transl Lung Cancer Res       Date:  2022-05

6.  Genome-wide risk prediction of common diseases across ancestries in one million people.

Authors:  Nina Mars; Sini Kerminen; Yen-Chen A Feng; Masahiro Kanai; Kristi Läll; Laurent F Thomas; Anne Heidi Skogholt; Pietro Della Briotta Parolo; Benjamin M Neale; Jordan W Smoller; Maiken E Gabrielsen; Kristian Hveem; Reedik Mägi; Koichi Matsuda; Yukinori Okada; Matti Pirinen; Aarno Palotie; Andrea Ganna; Alicia R Martin; Samuli Ripatti
Journal:  Cell Genom       Date:  2022-04-13

7.  Stability of polygenic scores across discovery genome-wide association studies.

Authors:  Laura M Schultz; Alison K Merikangas; Kosha Ruparel; Sébastien Jacquemont; David C Glahn; Raquel E Gur; Ran Barzilay; Laura Almasy
Journal:  HGG Adv       Date:  2022-01-21

Review 8.  Early Diagnosis, Early Stratification, and Early Intervention to Deliver Precision Medicine in IBD.

Authors:  Nurulamin M Noor; Paula Sousa; Stéphane Paul; Xavier Roblin
Journal:  Inflamm Bowel Dis       Date:  2022-08-01       Impact factor: 7.290

Review 9.  Multi-omics approach to precision medicine for immune-mediated diseases.

Authors:  Mineto Ota; Keishi Fujio
Journal:  Inflamm Regen       Date:  2021-08-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.